http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101439255-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101439255-B1
titleOfInvention The New Tenofovir disoproxil salt and the preparation method thereof
abstract The present invention relates to novel tenofovir disoproxil aspartate compounds. The salt compound can minimize the generation of a flexible substance according to changes over time as compared with the terbinafide disoproxil fumarate salt, so that the stability of the preparation can be improved by greatly reducing the amount of impurities generated during storage of the product containing the salt compound , Eliminating the need to perform separate studies of toxic effects. In addition, since the salt compound of the present invention greatly improves the stability, the wetting property and the solubility according to the pH change and has a physico-chemical property, it can be used for the treatment of HIV-1 infection and chronic hepatitis B together with a pharmaceutically acceptable carrier May be used as an active ingredient of a pharmaceutical composition useful in the present invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180064213-A
priorityDate 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009074351-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010026603-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58850801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425692911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453266653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424043453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505042

Total number of triples: 45.